BRAF and melanoma: Although lower expression of these three miRNAs discriminated well distant melanoma development, death of melanoma and lower survival rates, similarly in both groups, independently of BRAF mutational status, not all of them resulted to be significant prognostic factors for MSS and DMFS in the respective groups.